Reports Q4 revenue $60.6M, consensus $58.45M. "Definitive Healthcare once again delivered in 2022 with a 34% year-over-year revenue growth rate and a 29% adjusted EBITDA margin – representing a Rule of 63 Performance." said Robert Musslewhite, CEO of Definitive Healthcare. "This unique combination of high growth and profitability allows us to continue to effectively grow and scale the business, while maintaining a clear focus on maximizing our long-term success and value creation for customers and shareholders."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DH:
- Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2022
- Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast
- Definitive Healthcare expands all-payor medical, prescription claims coverage
- Definitive Healthcare introduces the Atlas Dataset
- Definitive Healthcare greatly expands all-payor medical and prescription claims coverage
